title: Physical and laboratory measurements in the PEPI Trial Postmenopausal Estrogen/Progestin Interventions.
authors.affiliation: Stanford University, Stanford Center for Research in Disease Prevention, Palo Alto, CA, USA.
authors.forename: P D
authors.initials: PD
authors.lastname: Wood
authors.forename: G
authors.initials: G
authors.lastname: Kessler
authors.forename: K
authors.initials: K
authors.lastname: Lippel
authors.forename: M L
authors.initials: ML
authors.lastname: Stefanick
authors.forename: C H
authors.initials: CH
authors.lastname: Wasilauskas
authors.forename: H B
authors.initials: HB
authors.lastname: Wells
mesh_terms: D000886:Anthropometry; D001774:Blood Chemical Analysis; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D045167:Progesterone Congeners / Q000008:administration & dosage* / Q000009:adverse effects; D011786:Quality Control; D016896:Treatment Outcome
chemical_list: D008055:Lipids; D045167:Progesterone Congeners